We hope you find everything you need to understand how Idorsia intends to achieve its ambitious goals. If you need any further support please don't hesitate to reach out to us.
Idorsia offers an electronic ‘Stay informed’ service. You will get the news sent to you.
|9 Months 2018 Financial Results reporting||October 23, 2018|
|Full-Year 2018 Financial Results reporting||February 7, 2019|
|First Quarter 2019 Financial Results reporting||April 18, 2019|
Read all the latest financial information from Idorsia.
Find out more about the key priorities that management has set in order to develop Idorsia into one of Europe’s leading biopharmaceutical company.
Idorsia has a diversified clinical development pipeline in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders, and orphan diseases.
Find out more about Idorsia.